C. Lopez

Effects of betamethasone, sulindac and quinacrine drugs on the inflammatory neoangiogenesis response induced by polyurethane sponge implanted in mouse.

D. Lemus, A. Dabancens, M. Fuenzalida, 2002, Biological research.

Su1858 – Real-World Effectiveness and Safety of Vedolizumab and Anti-TNF in Biologic-Naive Ulcerative Colitis Patients: Results from the Evolve Study

M. Silverberg, B. Bressler, M. Walshe, 2019, Gastroenterology.

P632 Etrasimod induction therapy in moderately to severely active Crohn’s disease: results from a phase 2, randomised, double-blind substudy

G. D'Haens, L. Peyrin-Biroulet, S. Danese, 2023, Journal of Crohn's and Colitis.

638 Clinical Effectiveness of First-Line Anti-TNF Therapies and Second-Line Anti-TNF Therapy Post-Vedolizumab Discontinuation in Patients With Ulcerative Colitis or Crohn's Disease

U. Kopylov, B. Bressler, G. Mantzaris, 2019, American Journal of Gastroenterology.